Animal study · rats

Hexarelin protected rat hearts from ischemia-reperfusion damage

Checked against the paper Animal studyPublished by PepVault

The takeaway

In rats, hexarelin's protective effect on the heart after blood flow was cut and restored did not depend on growth hormone; this study did not test people.

Kind
Animal study
Studied in
Rats
Published
1999
Journal
Endocrinology

What they tested

The team tested whether hexarelin protects the heart in rats in a way that does not depend on growth hormone (GH).

How the study was done

A rat study in hypophysectomized rats (the pituitary gland removed, so they lack GH), treated for 7 days with hexarelin, GH, or EP 51389, another GH-releasing peptide that does not bind to the heart. Their hearts were then removed and put through ischemia-reperfusion, where blood flow is stopped and then restored.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking hexarelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, hexarelin given at 80 microg/kg under the skin for 7 days kept the pituitary removal from making the ischemia-reperfusion damage worse. It kept left ventricular end diastolic pressure and coronary perfusion pressure from rising, limited how strongly the heart's blood vessels reacted to angiotensin II, and reduced creatine kinase release into the fluid passing through the heart. It also stopped the drop in prostacyclin release and helped the heart's pumping strength (contractility) recover better. GH at 400 microg/kg gave similar results, while EP 51389 at 80 microg/kg had no effect, which the authors read as hexarelin likely acting through specific receptors in the heart rather than through GH.

What it doesn’t show

This was done in rats, with hearts tested after removal from the body, so it is not a human result. Treatment lasted only 7 days, and the study tested damage from one ischemia-reperfusion model, not long-term heart health.

The paper

Locatelli et al. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 1999.

The compound

More studies on Hexarelin

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking hexarelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo